New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

Michigan officials are urging residents to test their homes for a dangerous, radioactive gas that is found naturally in the ...

“Bev has significant kyphoscoliosis (curvature of the spine that’s both sideways and forward/backward), which made the biopsy ...

Even though lung and related cancer deaths decreased in the world's 10 most populous countries from 1990 to 2019, these ...

Kenneth Dootson, of Marlborough, died prematurely at age 75 because of Yale's misdiagnosis of cancer that had spread to his ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...

Radon is colorless, odorless and the U.S.'s second-most common cause of lung cancer. Here's where you can get a free radon ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for lung cancer, leveraging mucoadhesive protein nanoparticles inspired by the ...